Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy
Epilepsy & Behavior · 2025
DOI: 10.1016/j.yebeh.2025.110583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Qian Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Exploratory Behavior, Open Field Test, Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: University of Washington - Seattle Campus.
Abstract (Originalsprache)
Antiseizure medications (ASMs) cause both acute and chronic behavioral side effects in individuals with epilepsy. While clinical and preclinical studies often focus on chronic effects, the acute dose-related impact of ASMs on behavior is underreported, especially in rodent temporal lobe epilepsy (TLE) models. Investigating the acute effects of both therapeutic and behaviorally impairing doses may predict clinically relevant adverse effects, such as sedation, hyperactivity, and impaired coordination, which are essential for evaluating drug safety and tolerability. This study investigated the acute effects of anticonvulsant doses of carbamazepine (CBZ), valproic acid (VPA), levetiracetam (LEV), and cenobamate (CNB) on locomotor activity and exploratory behavior in male rats 8-13 weeks after kainic acid (KA)-induced status epilepticus (SE) elicited confirmed spontaneous recurrent seizures (SRS) consistent with TLE. Behavioral outcomes were quantified using an automated open field task (OFT) in both epileptic and non-epileptic (sham-SE) rats. Our findings reveal that the selected ASMs, at therapeutic doses, did not differentially impact exploratory behavior and anxiety-like behavior in either SRS or sham-SE rats. However, the motor impairing doses of CBZ and CNB equally suppressed exploratory behavior, likely due to sedative effects, in both epileptic and non-epileptic rats. VPA induced mild sedation without affecting exploration. LEV was unique, showing no sedative effects even at high doses. This study provides essential insight into the efficacy and tolerability profiles of a diversity of FDA-approved ASMs in a clinically relevant TLE model. Thus, SRS may influence ASM tolerability in preclinical TLE models used to inform clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA.
- Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA.
- Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA. Electronic address: mhaliski@uw.edu.
Förderung
- University of Washington - Seattle Campus
Zitieren
APA
Wu, Q., Zierath, D., Knox, K. M., Steve White, H., & Barker-Haliski, M. (2025). Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110583
Vancouver
Wu Q, Zierath D, Knox KM, Steve White H, Barker-Haliski M. Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110583
BibTeX
@article{Wu2025,
author = {Wu, Qian and Zierath, Dannielle and Knox, Kevin M and Steve White, H and Barker-Haliski, Melissa},
title = {Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy},
journal = {Epilepsy & Behavior},
year = {2025},
doi = {10.1016/j.yebeh.2025.110583}
}
EUVIMED